FDA Adverse Event Malfunction Summary report: N

TI PSPC MATRIXMANDIBLE 7X23 H ANGLE RECON PL/LEFT/2.0MM THK

MDR report key: 3013562 · Received March 20, 2013

Report

Report Number
2530088-2013-10264
Event Type
Malfunction
Date Received
March 20, 2013
Date of Event
February 27, 2012
Report Date
February 27, 2012
Manufacturer
SYNTHES BRANDYWINE
Product Code
JEY
PMA / PMN Number
K063790
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

SYNTHES IS SUBMITTING THIS REPORT AS A RESULT OF REMEDIATION ACTIVITIES RELATED TO FDA WARNING LETTER DATED FEBRUARY 2012. DEVICE(S) LISTED IN THIS REPORT IS (ARE) USED FOR TREATMENT, NOT DIAGNOSIS. ANY ADDITIONAL INFORMATION RECEIVED REGARDING THIS EVENT AFTER FILING THIS REPORT SHALL BE FILED ON A SUPPLEMENTAL MDR. NO SAMPLE WAS RETURNED FOR EVALUATION. A REVIEW OF THE DEVICE HISTORY RECORD DID NOT SHOW CONDITIONS THAT COULD HAVE CONTRIBUTED TO THE REPORTED EVENT. THIS COMPLAINT IS CONSIDERED INVALID FROM A MANUFACTURING PERSPECTIVE.

Additional Manufacturer Narrative · 1

SYNTHES IS SUBMITTING THIS REPORT AS A RESULT OF REMEDIATION ACTIVITIES RELATED TO FDA WARNING LETTER DATED FEBRUARY 2012. DEVICE(S) LISTED IN THIS REPORT IS (ARE) USED FOR TREATMENT, NOT DIAGNOSIS. ANY ADDITIONAL INFORMATION RECEIVED REGARDING THIS EVENT AFTER FILING THIS REPORT SHALL BE FILED ON A SUPPLEMENTAL MDR.

Description of Event or Problem · 1

IT WAS REPORTED THAT WHEN PLACING THE SCREWS INTO THE PLATE/MANDIBLE, THE 2.0MM MATRIX MANDIBLE SCREW PASSED THROUGH THE PLATE RATHER THAN LOCKING AS INTENDED. SURGEON USED 2.4MM MATRIX MANDIBLE SCREW AND IT WAS SUCCESSFULLY PLACED. PROCEDURE WAS COMPLETED. THE PATIENT WAS UNHARMED.

Description of Event or Problem · 1

THIS IS REPORT 1 OF 1 FOR COMPLAINT (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
115612 TI PSPC MATRIXMANDIBLE 7X23 H ANGLE RECON PL/LEFT/2.0MM THK JEY SYNTHES BRANDYWINE 6887168

Patients

Seq Age Sex Outcome Treatment
1 7 YR